Lung Cancer Drug Hope

A Spanish biotechnology company Zeltia has announced that its preclinical trials of Irvalec a lung cancer medication have shown positive results. The company has said the experiments have shown 'efficiency' in treating lung cancer. This brings hope to the lung cancer awareness and treatment arena. Reuters released the report saying, "The results were presented at an American Association for Cancer Research (AACR) conference in Denver from April 18-22, where Zeltia said it also presented promising data on other drugs in its pipeline." Although this is great preliminary news on the medication treatment front, it is vital to lung health and prevention that people at high risk get regular lung scans and check-ups. The key to treating lung cancer is early detection.